Paul Shaughnessy, MD

Articles by Paul Shaughnessy, MD

Dr. Shaughnessy Outlines FELIX Trial of Obe-Cel in Relapsed, Refractory B-ALL

Patrick DalyAcute Lymphoblastic Leukemia | September 16, 2024

Of the 127 patients who received obe-cel infusion, 74% achieved CR/CRi and 95% had MRD negativity.